Doç. Dr. Emre HOCA

1. The Relationship Between Pituitary Axis Hormones and All-Cause Mortality in Hospitalized Patients with Chronic Diseases: A Prospective Cohort Study

Havare E., Topçu G., Yıldız P., HOCA E., ATAOĞLU H. E.

Medicina (Lithuania) , cilt.62, sa.3, 2026 (SCI-Expanded, Scopus)

2. Determinants of anemia in patients with primary glomerulonephritis: a biopsy-based analysis

Urvasızoğlu A. Ö., HOCA E., CEBECİ E., UZUN S., KARADAĞ S., Öztürk S.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.81, sa.2, ss.70-79, 2026 (SCI-Expanded, Scopus)

3. Diagnostic Performance of Plasma Levels of sST2 (Soluble Suppression of Tumorigenicity 2) in the Evaluation of Hypervolemia in Hemodialysis Patients: A Comparative Analysis With Traditional and Alternative Biomarkers

Hartavi E. C., UZUN S., KARADAĞ S., HOCA E., Çelik A., Oğuz H., et al.

Hemodialysis International , 2026 (SCI-Expanded, Scopus)

4. Low Serum Uric Acid as an Independent Predictor of Mortality and Poor Prognosis: A Retrospective Cohort Study

Şahin S. İ., Çiftçi Öztürk E., Öztürk H., Çetintulum Aydın B., Ziyadanoğlu Cezairli F. P., HOCA E., et al.

Journal of Clinical Medicine , cilt.14, sa.19, 2025 (SCI-Expanded, Scopus)

5. The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients

HOCA E., Cangir B., AHBAB S., Şahin S. İ., Çiftçi Öztürk E., Urvasızoğlu A. Ö., et al.

Diagnostics , cilt.15, sa.16, 2025 (SCI-Expanded, Scopus)

6. The Impact of SGLT2 Inhibitors on Hemoglobin Levels in Type 2 Diabetes: Potential Benefits Beyond Glycemic and Renal Outcomes

HOCA E., Kalayci N.

Haseki Tip Bulteni , cilt.63, sa.3, ss.141-149, 2025 (ESCI, Scopus, TRDizin)

7. The Impact of Metformin on BNP Levels: A Potential Cardioprotective Role in Type 2 Diabetes

HOCA E., Kalaycı N., AHBAB S., Engin İ., ATAOĞLU H. E.

Journal of Clinical Medicine , cilt.14, sa.8, 2025 (SCI-Expanded, Scopus)

8. The effects of chronic kidney disease stages on dyslipidemia, cardiovascular disease prevalence and mortality

HOCA E., Mermer H. B., Kula A. C., AHBAB S., ATAOĞLU H. E.

Northern Clinics of Istanbul , cilt.12, sa.1, ss.95-102, 2025 (ESCI, Scopus, TRDizin)

9. Comparison of Controlling Nutritional Status Score with Bedside Index for Severity in Acute Pancreatitis Score and Atlanta Classification for Mortality in Patients with Acute Pancreatitis

Çavuşoğlu Türker B., AHBAB S., Türker F., HOCA E., Çiftçi Öztürk E., Kula A. C., et al.

Journal of Clinical Medicine , cilt.13, sa.12, 2024 (SCI-Expanded, Scopus)

10. Hypermagnesemia is associated with poor outcomes during hospitalization

HOCA E., Arat E. K., Arat O., AHBAB S., Kula A. C., Öztürk H., et al.

Irish Journal of Medical Science , cilt.193, sa.2, ss.733-739, 2024 (SCI-Expanded, Scopus)

11. Evaluation of Pulmonary Embolism Risk Stratification Scores in Patients Admitted to the Internal Medicine Clinic

Ercin E., HOCA E.

Haseki Tip Bulteni , cilt.62, sa.1, ss.41-46, 2024 (ESCI, Scopus, TRDizin)

12. Serum albumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated Charlson Comorbidity Index)

Turker B. C., Turker F., AHBAB S., HOCA E., Tahmaz M., ATAOĞLU H. E.

PLoS ONE , cilt.17, sa.3 March, 2022 (SCI-Expanded, Scopus)

13. Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients

Cavuşoğlu Türker B., Türker F., AHBAB S., HOCA E., Urvasızoğlu A. O., Cetin S. I., et al.

International Journal of General Medicine , cilt.15, ss.6301-6307, 2022 (SCI-Expanded, Scopus)

Doç. Dr. Emre HOCA

Yayınlar & Eserler

1. The Relationship Between Pituitary Axis Hormones and All-Cause Mortality in Hospitalized Patients with Chronic Diseases: A Prospective Cohort Study

2. Determinants of anemia in patients with primary glomerulonephritis: a biopsy-based analysis

3. Diagnostic Performance of Plasma Levels of sST2 (Soluble Suppression of Tumorigenicity 2) in the Evaluation of Hypervolemia in Hemodialysis Patients: A Comparative Analysis With Traditional and Alternative Biomarkers

4. Low Serum Uric Acid as an Independent Predictor of Mortality and Poor Prognosis: A Retrospective Cohort Study

5. The Triglyceride/HDL Ratio as a Non-Invasive Marker for Early-Stage NAFLD: A Retrospective Cross-Sectional Study of 2588 Patients

6. The Impact of SGLT2 Inhibitors on Hemoglobin Levels in Type 2 Diabetes: Potential Benefits Beyond Glycemic and Renal Outcomes

7. The Impact of Metformin on BNP Levels: A Potential Cardioprotective Role in Type 2 Diabetes

8. The effects of chronic kidney disease stages on dyslipidemia, cardiovascular disease prevalence and mortality

9. Comparison of Controlling Nutritional Status Score with Bedside Index for Severity in Acute Pancreatitis Score and Atlanta Classification for Mortality in Patients with Acute Pancreatitis

10. Hypermagnesemia is associated with poor outcomes during hospitalization

11. Evaluation of Pulmonary Embolism Risk Stratification Scores in Patients Admitted to the Internal Medicine Clinic

12. Serum albumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated Charlson Comorbidity Index)

13. Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim